Verapamil Hydrochloride

盐酸维拉帕米

Report date: 2025/07/25 14:29:41
NME

Base Information

Drug NameVerapamil Hydrochloride
Drug Alias Name维拉帕米盐酸盐VerapamilumVerapamilo异搏停戊脉安 +[18] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsIschemic StrokeBipolar DisorderDiabetes Mellitus, Type 1 +[15] 
Global Approved IndicationsHypertensionAngina PectorisTachycardia, Supraventricular +[5] 
Approved Indications in ChinaHypertensionAngina Pectoris
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryBelgiumUnited StatesItaly +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesArisyn
China Registration ClassN/A

Develop Information

Active CompaniesJaeb Center For Health Research IncMedical University Of GrazBenaroya Research Institute +[8] 
Inactive CompaniesCalosyn Pharma IncMylan Pharmaceuticals IncPfizer Inc +[9] 
Active IndicationsIschemic StrokeDiabetes Mellitus, Type 1Essential Hypertension +[5] 
Inactive IndicationsBipolar DisorderCardiomyopathy, HypertrophicTachycardia, Supraventricular +[10] 

Other Information

ATC CodeC08DA01
Related LinksWikipediaDrugBankKEGG